LONDON BROKER RATINGS: Stifel prefers AstraZeneca over GlaxoSmithKline

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

Stifel starts GlaxoSmithKline with 'hold' - price target 1,700 pence

----------

Stifel starts AstraZeneca with 'buy' - price target 12,300 pence

----------

Jefferies cuts Ferguson to 'hold' (buy) - price target 12,374 (15,708) pence

----------

Kepler Cheuvreux cuts BP price target to 420 (485) pence - 'buy'

----------

Berenberg cuts BP price target to 450 (475) pence - 'buy'

----------

JPMorgan cuts BP price target to 500 (600) pence - 'overweight'

----------

Jefferies cuts Aveva to 'underperform' (hold) - price target 2,000 (3,300) pence

----------

JPMorgan raises BAE Systems price target to 710 (630) pence - 'neutral'

----------

UBS raises BAE Systems price target to 630 (575) pence - 'neutral'

----------

JPMorgan raises Anglo American price target to 3,050 (2,900) pence - 'neutral'

----------

Berenberg raises Rightmove price target to 740 (710) pence - 'hold'

----------

Berenberg raises HSBC price target to 560 (470) pence - 'hold'

----------

UBS cuts IAG price target to 215 (220) pence - 'buy'

----------

Barclays cuts IAG price target to 210 (220) pence - 'overweight'

----------

Barclays raises Pearson price target to 630 (610) pence - 'underweight'

----------

Barclays raises Standard Chartered target to 700 (590) pence - 'equal weight'

----------

Berenberg raises WPP price target to 1,185 (1,045) pence - 'hold'

----------

FTSE 250

----------

Barclays cuts Jupiter Fund Management price target to 210 (280) pence - 'underweight'

----------

JPMorgan cuts Jupiter Fund price target to 240 (290) pence - 'neutral'

----------

JPMorgan raises Qinetiq to 'neutral' ('underweight') - target 320 (260) pence

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.